Savara (SVRA) Preferred Dividend Payments (2010 - 2017)
Savara (SVRA) posted quarterly Preferred Dividend Payments of $554000.0 for Q2 2017, up 27600.0% year-over-year from N/an in Q2 2016, and up 2208.33% quarter-over-quarter from $24000.0 in Q1 2017.
Savara (SVRA) Preferred Dividend Payments (2010 - 2017) Analysis & Trends
Savara (SVRA) has reported Preferred Dividend Payments for 3 consecutive years, with $554000.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Preferred Dividend Payments rose 27600.0% year-over-year to $554000.0; the TTM figure through Dec 2017 stood at $578000.0 (down 94.91% YoY), while the FY2017 annual figure was $578000.0, up 514.89% from the prior year.
- Preferred Dividend Payments grew to $554000.0 in Q2 2017 per SVRA's latest filing, from $24000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $554000.0 in Q2 2017 and bottomed at $2000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 554,000.00 |
| Mar 31, 2017 | 24,000.00 |
| Dec 31, 2016 | 24,000.00 |
| Sep 30, 2016 | 44,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Dec 31, 2010 | 11.28 Mn |
| Jun 30, 2010 | -3.12 Mn |